Opis Research

CROPrivate Company
Milan, Italy
1998
Founded
200-500
Employees
1,500
Trials supported

About Opis Research

As data-driven and quality-focused clinical CRO, OPIS collaborates with numerous international Sponsors on multi-country interventional as well as non-interventional trials. OPIS teams have sound experience in a wide range of therapeutic areas, new-generation drugs, advanced therapeutic procedures and biologic treatment options. Medical and scientific expertise in combination with technological and operational know-how have earned OPIS established partnerships with numerous pharma and biotechnology and medical device clients. Example services include: Study Management Regulatory Pre-Clinical Medical Affairs Safety Vigilance Quality Assurance Study Data Solutions Clinical.net EDC

Services

Therapeutic areas

Experience & capabilities

Trial phases:Phase 1Phase 2Phase 3Phase 4
Products:Therapeutic productsMedical DevicesDiagnosticsVaccines
Trial geography:Global

Browse companies by location

Milan, ItalyItaly

Similar CRO companies in Italy

Austin, United States·10-50 employees
Melbourne, Australia·10-50 employees

Alithia Life Sciences is a premier Australian integrated service provider, specializing in clinical operational management including full service CRO capabilities. Our bespoke…

Lenexa, United States·500-5,000 employees

Integrated Expertise for Complex Clinical Development Modern clinical trials—especially those with complex, innovative designs—require a coordinated, cross-functional approach to…

Bremen, Germany·50-200 employees

We are a privately owned, full service CRO with an expertise in conduct of clinical trials. We conduct a broad range of trials every year, from phase I through phase IV trials…

Noida, India·50-200 employees

IR Innovate Research is a regulatory compliant full-service Contract Research Organization With a strategic presence across the globe, We specialize in providing End-to-End…

Montreal, Canada·50-200 employees

In 2025, the MHICC became Seriant to reflect our commitment to driving transformation across a wider range of therapeutic areas. We continue to expand our reach beyond cardiology,…